A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

According to Amanda, both children have faced challenges in adapting. Peyton is still grappling with the loss of another ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal squamous cell carcinoma.

A Midtown-based diagnostics company raised capital in a deal to advance its novel approach to screening for the risk factors ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

With further testing, discovery may offer new target for early detection and treatmentResearchers at Case Western Reserve ...